{"keywords": [{"value": "23andMe", "rank": "1", "is_major": "Y", "name": "organizations"}, {"value": "Genetics and Heredity", "rank": "2", "is_major": "Y", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "rank": "3", "is_major": "N", "name": "subject"}, {"value": "DNA (Deoxyribonucleic Acid)", "rank": "4", "is_major": "N", "name": "subject"}, {"value": "Wojcicki, Anne", "rank": "5", "is_major": "N", "name": "persons"}, {"value": "Computers and the Internet", "rank": "6", "is_major": "N", "name": "subject"}], "headline": {"print_headline": "23andMe Will Resume Giving Users Health Data ", "main": "23andMe Will Resume Giving Users Health Data "}, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "organization": "", "lastname": "POLLACK", "firstname": "Andrew"}]}, "web_url": "http://www.nytimes.com/2015/10/21/business/23andme-will-resume-giving-users-health-data.html", "source": "The New York Times", "subsection_name": null, "slideshow_credits": null, "type_of_material": "News", "_id": "56270e1238f0d85d3d8b36f3", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/10/21/business/21GENE/21GENE-thumbWide.jpg"}, "type": "image", "width": 190, "url": "images/2015/10/21/business/21GENE/21GENE-thumbWide.jpg"}, {"height": 834, "subtype": "xlarge", "legacy": {"xlargeheight": "834", "xlargewidth": "600", "xlarge": "images/2015/10/21/business/21GENE/21GENE-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2015/10/21/business/21GENE/21GENE-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnailheight": "75", "thumbnail": "images/2015/10/21/business/21GENE/21GENE-thumbStandard.jpg"}, "type": "image", "width": 75, "url": "images/2015/10/21/business/21GENE/21GENE-thumbStandard.jpg"}], "pub_date": "2015-10-21T00:00:00Z", "print_page": "3", "section_name": "Business Day", "word_count": "784", "blog": [], "news_desk": "Business", "snippet": "The genetic-testing company stopped providing health information in 2013 after the F.D.A. ordered it to prove the accuracy of results.", "document_type": "article", "abstract": "23andMe announces it will re-start providing its customers with health and ancestry information based on their saliva, practice it was ordered to stop in 2013 by Food and Drug Administration; company hopes shift will increase number of subscriptions to its genetic testing service.", "lead_paragraph": "The genetic-testing company stopped providing health information in 2013 after the F.D.A. ordered it to prove the accuracy of results."}